Delirium, Dementia, Amnestic, Cognitive Disorders  >>  AZD-5213  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD-5213 / AstraZeneca
NCT01548287: A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive Impairment

Completed
2a
164
US
AZD5213, Placebo
AstraZeneca
Mild Cognitive Impairment, Mild Alzheimer's Disease
01/13
01/13

Download Options